Botulinum toxin urethral sphincter injection resolves urinary retention after pubovaginal sling operation.
The management of prolonged urinary retention following pubovaginal sling surgery typically involves transvaginal urethrolysis for anatomical urethral obstruction. Brubaker [1] recently reported on urethral sphincter abnormalities as a cause of postoperative urinary retention following either Burch suspension or pubovaginal sling procedure. We report a case of functional urethral obstruction and detrusor acontractility following pubovaginal sling surgery that was successfully treated by botulinum A toxin urethral sphincter injection.
Smith
C P
CP
University of Pittsburgh School of Medicine, 3471 Fifth Avenue, Pittsburgh, PA 15213, USA.
O'Leary
M
M
Erickson
J
J
Somogyi
G T
GT
Chancellor
M B
MB
D000368:Aged; D001905:Botulinum Toxins / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007267:Injections; D011183:Postoperative Complications / Q000628:therapy*; D016896:Treatment Outcome; D014521:Urethra; D014524:Urethral Obstruction / Q000628:therapy; D014550:Urinary Incontinence, Stress / Q000601:surgery; D016055:Urinary Retention / Q000503:physiopathology / Q000628:therapy*; D014563:Urodynamics; D013519:Urogenital Surgical Procedures
D001905:Botulinum Toxins